Navigation Links
Transition Therapeutics Announces First Quarter Fiscal 2009 Financial Results
Date:11/10/2008

candidate ELND005 (AZD-103).

On August 30, 2007, the Company announced the completion of Phase I clinical studies with ELND005 (AZD-103). Transition and its development partner Elan have performed multiple Phase I studies evaluating the safety, tolerability and pharmacokinetic profile of ELND005 (AZD-103) in healthy volunteers. Approximately 110 subjects have been exposed to ELND005 (AZD-103) in multiple Phase I studies, including single and multiple ascending dosing; pharmacokinetic evaluation of levels in the brain; and CSF and plasma studies. ELND005 (AZD-103) was safe and well-tolerated at all doses and dosing regimens examined. There were no severe or serious adverse events observed. ELND005 (AZD-103) was also shown to be orally bio-available, cross the blood-brain barrier and achieve levels in the human brain and CSF that were shown to be effective in animal models for Alzheimer's disease.

On December 21, 2007, Elan and Transition announced that the first patient had been dosed in a Phase II clinical study of ELND005 (AZD-103) in patents with Alzheimer's disease. The study is a randomized, double-blind, placebo-controlled, dose-ranging, safety and efficacy study in approximately 340 patients with mild to moderate Alzheimer's disease. The study will evaluate both cognitive and functional endpoints, and each patient's participation is planned to last approximately 18 months.

On October 20, 2008, Elan and Transition announced the patient enrollment target for the Phase 2 clinical study of ELND005 (AZD-103) in patients with Alzheimer's disease was achieved.

TT-223 for Diabetes

Pre-clinical data in diabetes animal models demonstrate the efficacy of gastrin analogues alone, or in combination with GLP-1 analogues or epidermal growth factor analogues. In humans, Transition's Phase IIa clinical trial data showed that a 4-week therapy with TT-223 in combination with EGF (combination of gastrin analogue and epidermal growth factor analo
'/>"/>

SOURCE Transition Therapeutics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Respiratory Leaders Urge Medical Community to Educate Patients Transitioning CFC to HFA Inhalers
2. Transitions Optical to Provide Free Vision Screenings at the American Diabetes Associations Feria de Salud por tu Familia(TM)
3. Transition Therapeutics to Hold Conference Call on First Quarter Fiscal 2009 Financial Results on Monday, November 10th, at 4:30 P.M. EST
4. Schering-Plough Announces Transition of Animal Health Leadership
5. ACS Signs $27 Million Contract with Alaska to Transition Fiscal Agent Services for State Medicaid Program
6. MidSouth eHealth Alliance to Transition to Commercial Software Solution from Informatics Corporation of America
7. Transition Therapeutics Announces No Material Change
8. Transitions Optical Offers Tips on How to Protect Eyes for Outdoor Sports Fans
9. Transition Therapeutics Announces Executive Management Appointments
10. AGA Medical Announces Management Transition
11. Booth Radiology Associates Chooses IDC To Complete Its Transition To Digital Imaging
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... August 29, 2014 Daily Gossip reveals in ... is a new method of naturally curing this disease. ... leading to a permanent cure in only one week. This ... no need to make huge sacrifices. , Moreover, with ... from the symptoms of sciatica in just 8 minutes. ...
(Date:8/29/2014)... famous online supplier of trendy clothes, has unveiled its new ... all these mini outfits are offered at discounted rates, up ... September 14. , The company’s senior spokesman states, “To ... designs, we have listed some of the best-selling items in ... to get high quality, fashionable clothes. Many of our sexy ...
(Date:8/29/2014)... August 29, 2014 Indosoft, Inc., a ... the availability of monthly per-port licensing of its Q-Suite ... contact center solutions, Indosoft has been successfully deploying and ... and large contact centers around the world for more ... intended to give clients another option which complements the ...
(Date:8/29/2014)... (PRWEB) August 30, 2014 Developed as ... DoudouneCanadienneGoosePasCher.fr’s high quality Canada Goose products offer ... when working on Arctic runways. The company’s Canada ... jackets in the current market. Additionally, the firm has ... special offer. , At present, all high quality ...
(Date:8/29/2014)... 29, 2014 As reported by GantDaily.com in ... Drug Abuse Trends , Outbreaks (8/20), the National Institute on ... monitor drug abuse trends by turning to social media. As ... trends, it is also working with the University of Maryland ... Early Warning System, which will be funded by the National ...
Breaking Medicine News(10 mins):Health News:Stop Sciatica in 8 Minutes Review Exposes Steven Guo's Complete Sciatica Cure 2Health News:Cheap Sexy Mini Dresses Added To The Product Line Of Skmen.com 2Health News:Indosoft Offers Monthly Usage Licensing Terms 2Health News:New Designs Of Canada Goose Chilliwack Bombers From DoudouneCanadienneGoosePasCher.fr 2Health News:Social Media Proves to Be Helpful in Fighting Drug Abuse 2Health News:Social Media Proves to Be Helpful in Fighting Drug Abuse 3
... of developing eczema in babies is reduced by adding prebiotics ... gut bacteria //and fortifies the immune system. ... for Infant Nutrition revealed that topic dermatitis was ... than in those given the standard form. The results, published ...
... Association it was found that people were not interested to ... about health policy and speedy treatment. ,But in ... the public with a choice of hospitals. ... annual representative meeting in Belfast. The policy was prepared mostly ...
... Scientists have announced that they have discovered a new way ... a research that was published yesterday. // ,The ... make the brain repair itself after a stroke. In their ... suffering from an induced stroke, that after their treatment there ...
... Australian Therapeutic Goods Administration (TGA) has approved the cervical cancer ... ,Early June had seen the US Food and Drug ... in the United States for girls and women aged from ... by CSL. The vaccine was invented by University of Queensland ...
... New diagnosis method to monitor the production and clearance ... tracking human brain disorders. // ,Amyloid ... system of humans can now be possibly diagnosed with ... Washington University School of Medicine in St. Louis. ...
... African American women could be more prone to diabetes ... a protein hormone, present in fat cells. // ... results of their study that examined the relationships between ... ADIPO is known as a hormone that regulates the ...
Cached Medicine News:Health News:New Discovery Shows That Brain Could repair Itself After Stroke 2Health News:Abnormal Abeta - Protein Level in Human Brain Trigger Alzheimer's Risk 2Health News:Abnormal Abeta - Protein Level in Human Brain Trigger Alzheimer's Risk 3Health News:Fat Cell Hormone Could Trigger Diabetes, Heart Disease 2
(Date:8/29/2014)... -- In part four of a blog series ... a strategic asset, Mary Baxter, MBA, RPh ., ... Innovation Delivery Solutions business, discusses how expanding patient access ... patients. "Every hospital pharmacist knows that filling ... in a value-based healthcare world," Baxter says. "For the ...
(Date:8/29/2014)... Research and Markets  has announced the addition of ... 2014-2018" report to their offering. ... connect, support, or surround bones. There are several types ... fascia, and other fibrous tissues. Repetitive use, accidents, injuries, ... in wear and tear in these tissues. Orthopedic soft ...
(Date:8/28/2014)... YORK , Aug. 28, 2014 ... new market research report is available ... Laboratories, Safety and Compliance Services Industry ... and Revenue Forecasts to 2021, NAIC ... .html Testing Laboratories, ...
Breaking Medicine Technology:Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 2Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 4Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 3Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 2Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 3Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 4Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 5Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 6
... May 10, 2011 Cobalis Corp. (CLSC.PK) announced today ... PreHistin® Allergy Defense Formula , on major national cable ... commercials, featuring leading US allergist Dr. Paul H. Ratner, ... of allergies, giving seasonal and year-round sufferers the first ...
... May 10, 2011 Taylor Strategy Partners (TSP), who enable clients ... human capital for their organizations, is pleased to announce the expansion ... founded in 1969 and is headquartered in Columbus, OH with additional ... Vice President and Managing Director, will be taking the lead of ...
Cached Medicine Technology:Cobalis Corp. Launches National Television Commercials for PreHistin® Allergy Defense Formula 2Cobalis Corp. Launches National Television Commercials for PreHistin® Allergy Defense Formula 3Taylor Strategy Partners Set to Open Office in Kansas City in June 2011 2
They employ Lea Symbols. Contrast levels are the same at 25%, 10%, 5%, 2.5% and 1.25%. Each offers a different set of Lea Symbols to guard against memorization. Also uses recording forms (P/N 215400)...
9" X 14" Translucent plastic may be used with illuminated test cabinets or as a wall chart 20/100 to 20/10....
Angled 30 degree shaft. 13 mm from tip to bend with 2.5 mm hook curved tip. Polished finished. Overall length excluding hub: 35 mm, 1.4 inches....
Binkhorst irrigating cannula....
Medicine Products: